drugset / Trial / NCT03231605
Comparative Immunogenicity Study of Two Hepatitis A Vaccines
Phase 4
Unknown
300 enrolled
China National Biotec Group Company Limited
Shaanxi Provincial Center for Disease Control and Prevention · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
Hepatitis A is the most prevalent hepatitis which account for approximately 45% . The susceptible population is Children and adolescence, also the morbidity in adult presented rising trend in recent years. Therefore, vaccination of Hepatitis A Vaccine play an important role in National Immunisation Program(China). The aim of this experiment is to verify the effects of experimental group non-inferior than control group. The experiment methods is compared the difference of seroconversion rate and Antibody geometric mean titer (GMT)between experimental and control Hepatitis A Vaccines. In addition, evaluating the safety of two Hepatitis A Vaccines in 18-24 months Chinese Children.
Timeline
- Start
- 2017-07-26
- Primary completion
- 2017-08-31
- Completion
- 2017-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Havrix | Vaccine | — | — |